EMA Authorised: Veoza (fezolinetant) — Astellas Pharma Europe B.V.

View source ↗

Summary

Authorised European marketing approval for Veoza (fezolinetant) by Astellas Pharma Europe B.V. for menopause-related hot flashes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Menopause

Drugs mentioned

• Veoza (fezolinetant)

Snippet

Status: Authorised. Therapeutic area: Menopause;Hot Flashes. MAH: Astellas Pharma Europe B.V.. Decision date: 21/04/2026